Flputnam Investment Management Co. Buys Shares of 160,903 Phreesia, Inc. $PHR

Flputnam Investment Management Co. bought a new position in Phreesia, Inc. (NYSE:PHR) in the second quarter, according to its most recent disclosure with the SEC. The firm bought 160,903 shares of the company’s stock, valued at approximately $1,656,000. Flputnam Investment Management Co. owned about 0.26% of Phreesia as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of PHR. EverSource Wealth Advisors LLC grew its holdings in shares of Phreesia by 1,119.8% in the first quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock valued at $27,000 after purchasing an additional 3,001 shares during the period. Van ECK Associates Corp increased its position in Phreesia by 78.7% during the fourth quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock worth $42,000 after purchasing an additional 1,102 shares during the last quarter. New York State Teachers Retirement System purchased a new position in Phreesia during the first quarter worth about $44,000. Rockefeller Capital Management L.P. boosted its holdings in Phreesia by 354.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock valued at $47,000 after purchasing an additional 2,149 shares during the last quarter. Finally, Allworth Financial LP purchased a new stake in shares of Phreesia in the 2nd quarter valued at approximately $58,000. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Stock Up 0.2%

Phreesia stock opened at $12.17 on Monday. The company has a market capitalization of $752.23 million, a PE ratio of 81.13 and a beta of 0.85. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.76 and a current ratio of 1.76. Phreesia, Inc. has a fifty-two week low of $7.77 and a fifty-two week high of $32.74. The firm has a 50 day moving average price of $11.03 and a 200 day moving average price of $10.48.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on PHR shares. Canaccord Genuity Group cut their price target on shares of Phreesia from $22.00 to $16.00 and set a “buy” rating for the company in a report on Thursday, May 28th. DA Davidson reiterated a “buy” rating and issued a $14.00 price objective on shares of Phreesia in a research report on Thursday, May 28th. Citigroup reiterated a “market perform” rating on shares of Phreesia in a research report on Friday, May 29th. Piper Sandler downgraded Phreesia from an “overweight” rating to a “neutral” rating and set a $12.00 target price on the stock. in a research report on Thursday, May 28th. Finally, Wells Fargo & Company reaffirmed an “equal weight” rating and issued a $9.00 price target (down from $15.00) on shares of Phreesia in a research note on Wednesday, May 20th. Nine research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Phreesia has an average rating of “Hold” and an average target price of $16.65.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.